RxNorm 404786
Product containing carbidopa and entacapone and levodopa (medicinal product)
RxNorm Semantic Concepts
RxNorm semantic concepts for the RxCUI 404786 unique identifier include: carbidopa / entacapone / levodopa (12351862), Product containing carbidopa and entacapone and levodopa (medicinal product) (9254745) and Carbidopa- and entacapone- and levodopa-containing product (10798928).
RxNorm Atom ID: 12351862 - Multiple Ingredients
carbidopa / entacapone / levodopa
- RXCUI:
- 404786 - RxNorm Unique Identifier for a concept (Concept ID)
- LAT:
- ENG - Language of the Term
- RXAUI:
- 12351862 - Unique identifier for the atom (RxNorm Atom ID)
- Is Prescribable?
- YES - This drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
- Concept Description:
- carbidopa / entacapone / levodopa - Description of concept identifier
- Term Type (TTY):
- MIN - Term type in source with name and description
- Term Type Name:
- Multiple Ingredients - Name of term type in source
- Term Type Description:
- Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. - Description of term type in source
- Code:
- 404786 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
- Suppress Flag:
- N
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility. - CVF:
- 4096 - Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
- Source:
- RXNORM - Concept source abbreviation
- Source Name:
- RxNorm Vocabulary - The official name for a source
- Source Version:
- 20AA_240401F - The source version
- Source Date:
- March 04, 2024 - RxNorm data last updated
- Source License Contact:
- RxNorm Customer Service
U.S. National Library of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
(888) FIND-NLM
[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source license contact information - Source Content Contact:
- RxNorm Customer Service
U.S. National Library of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
(888) FIND-NLM
[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source content contact information - Source Short Name:
- RxNorm work done by the National Library of Medicine - The short name of a source as used by the NLM Knowledge Source Server
RxNorm Atom ID: 9254745 - Full form of descriptor
Product containing carbidopa and entacapone and levodopa (medicinal product)
- RXCUI:
- 404786 - RxNorm Unique Identifier for a concept (Concept ID)
- LAT:
- ENG - Language of the Term
- RXAUI:
- 9254745 - Unique identifier for the atom (RxNorm Atom ID)
- Is Prescribable?
- YES - This drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
- Concept Description:
- Product containing carbidopa and entacapone and levodopa (medicinal product) - Description of concept identifier
- Term Type (TTY):
- FN - Term type in source with name and description
- Term Type Name:
- Full form of descriptor - Name of term type in source
- Term Type Description:
- - Description of term type in source
- Code:
- 410860008 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
- Suppress Flag:
- N
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility. - CVF:
- - Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
- Source:
- SNOMEDCT_US - Concept source abbreviation
- Source Name:
- US Edition of SNOMED CT - The official name for a source
- Source Version:
- 2024_01_01 - The source version
- Source Date:
- March 04, 2024 - RxNorm data last updated
- Source License Contact:
- National Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)
https://support.nlm.nih.gov/support/create-case/
- The source license contact information - Source Content Contact:
- National Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library Of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)
https://support.nlm.nih.gov/support/create-case/
- The source content contact information - Source Short Name:
- US Edition of SNOMED CT - The short name of a source as used by the NLM Knowledge Source Server
RxNorm Atom ID: 10798928 - Designated preferred name
Carbidopa- and entacapone- and levodopa-containing product
- RXCUI:
- 404786 - RxNorm Unique Identifier for a concept (Concept ID)
- LAT:
- ENG - Language of the Term
- RXAUI:
- 10798928 - Unique identifier for the atom (RxNorm Atom ID)
- Is Prescribable?
- YES - This drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
- Concept Description:
- Carbidopa- and entacapone- and levodopa-containing product - Description of concept identifier
- Term Type (TTY):
- PT - Term type in source with name and description
- Term Type Name:
- Designated preferred name - Name of term type in source
- Term Type Description:
- - Description of term type in source
- Code:
- 410860008 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
- Suppress Flag:
- N
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility. - CVF:
- - Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
- Source:
- SNOMEDCT_US - Concept source abbreviation
- Source Name:
- US Edition of SNOMED CT - The official name for a source
- Source Version:
- 2024_01_01 - The source version
- Source Date:
- March 04, 2024 - RxNorm data last updated
- Source License Contact:
- National Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)
https://support.nlm.nih.gov/support/create-case/
- The source license contact information - Source Content Contact:
- National Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library Of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)
https://support.nlm.nih.gov/support/create-case/
- The source content contact information - Source Short Name:
- US Edition of SNOMED CT - The short name of a source as used by the NLM Knowledge Source Server
* This product uses publicly available data courtesy of the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Patient Education
Entacapone
Entacapone is an inhibitor of catechol-O-methyltransferase (COMT). It is used in combination with levodopa and carbidopa (Sinemet) to treat the end-of-dose 'wearing-off' symptoms of Parkinson's disease. Entacapone helps the levodopa and carbidopa work better by allowing more of it to reach the brain, where it has its effects. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
[Learn More]
Levodopa and Carbidopa
The combination of levodopa and carbidopa is used to treat the symptoms of Parkinson's disease and Parkinson's-like symptoms that may develop after encephalitis (swelling of the brain) or injury to the nervous system caused by carbon monoxide poisoning or manganese poisoning. Parkinson's symptoms, including tremors (shaking), stiffness, and slowness of movement, are caused by a lack of dopamine, a natural substance usually found in the brain. Levodopa is in a class of medications called central nervous system agents. It works by being converted to dopamine in the brain. Carbidopa is in a class of medications called decarboxylase inhibitors. It works by preventing levodopa from being broken down before it reaches the brain. This allows for a lower dose of levodopa, which causes less nausea and vomiting.
[Learn More]
* Please review the disclaimer below.